Received Feb 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
a first dose was administered on January nine twenty twenty-four/ late second dose/ did not receive 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 09-JAN-2024). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: a first dose was administered on January nine twenty twenty-four/ late second dose/ did not receive 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 04-FEB-2026 The registered pharmacist wanted to know about the patient's schedule and needed advice on this situation. The vaccine administration facility was the same as the primary reporter. The batch number was not provided upon follow- up with the reporter.